×
About 1,813 results

ALLMedicine™ Breast Biopsy Center

Research & Reviews  535 results

Evaluating breast biopsy practice and breast biopsy marker utilisation in the clinical ...
https://doi.org/10.1111/1754-9485.13451
Journal of Medical Imaging and Radiation Oncology; Radic R, Taylor DB

Jun 28th, 2022 - Breast Screen Australia and Breast Screen Aotearoa guidelines recommend breast biopsy marker (BBM) use in indicated patients. This study aims to evaluate breast biopsy practice and BBM utilisation by modality. An online survey was disseminated to ...

Evaluation of Breast CT
https://clinicaltrials.gov/ct2/show/NCT00584233

Jun 24th, 2022 - Clinical evaluation: Four hundred women who will be having breast biopsy as part of their standard care (BIRADS 4 and 5) will be recruited to undergo additional imaging prior to biopsy, including (research) pre-and post-contrast enhanced breast CT...

Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography ...
https://doi.org/10.1001/jamaoncol.2022.1990
JAMA Oncology; Lawson MB, Bissell MCS et. al.

Jun 24th, 2022 - Diagnostic delays in breast cancer detection may be associated with later-stage disease and higher anxiety, but data on multilevel factors associated with diagnostic delay are limited. To evaluate individual-, neighborhood-, and health care-level ...

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187292
The Breast Journal; Liew ALF, Lim HMY et. al.

Jun 18th, 2022 - To evaluate the potential of contrast-enhanced spectral mammography (CESM) in reducing benign breast biopsy rate, thereby improving resource utilization. To explore its potential as a value-adding modality in the management of BI-RADS 4/5 lesions....

e-Nature VR: Evaluation of the Impact of Virtual Reality During Breast Biopsy
https://clinicaltrials.gov/ct2/show/NCT03877094

May 31st, 2022 - Breast biopsy is one of the main tests for the diagnosis of cancer, which generates emotional distress and can be a painful procedure. Distraction has considerable efficacy among mild psychological methods for reducing pain perception. Virtual Rea...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  88 results

Evaluation of Breast CT
https://clinicaltrials.gov/ct2/show/NCT00584233

Jun 24th, 2022 - Clinical evaluation: Four hundred women who will be having breast biopsy as part of their standard care (BIRADS 4 and 5) will be recruited to undergo additional imaging prior to biopsy, including (research) pre-and post-contrast enhanced breast CT...

e-Nature VR: Evaluation of the Impact of Virtual Reality During Breast Biopsy
https://clinicaltrials.gov/ct2/show/NCT03877094

May 31st, 2022 - Breast biopsy is one of the main tests for the diagnosis of cancer, which generates emotional distress and can be a painful procedure. Distraction has considerable efficacy among mild psychological methods for reducing pain perception. Virtual Rea...

Breast Cancer BRCA1 Carriers: a Pilot Study
https://clinicaltrials.gov/ct2/show/NCT05062174

May 31st, 2022 - This is a single arm, prospective, observational trial enrolling up to 10 patients within Indiana University Simon Comprehensive Cancer Center. Eligible women will be consented to undergo breast biopsy 2-6 days prior to prophylactic mastectomy and...

HydroMARK Post-market Clinical Follow-up Study
https://clinicaltrials.gov/ct2/show/NCT04622696

Apr 26th, 2022 - The purpose of this study is to assess the safety and performance of the HydroMARK Breast Biopsy Site Marker manufactured in the Devicor Medical Products, Inc. Tijuana facility.

Evaluating the Value of Audio-guided Meditation During Breast Biopsy Procedures
https://clinicaltrials.gov/ct2/show/NCT05343975

Apr 25th, 2022 - audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.

see more →

News  59 results

Breast Cancer Trials Enrolling Now: Could Your Patient Benefit?
https://www.medscape.com/viewarticle/968608

Feb 16th, 2022 - A number of clinical trials in breast cancer have opened in recent months. Maybe one of your patients could benefit from being enrolled. Menopausal women at moderate risk of developing breast cancer. A phase 2 study sponsored by the National Cance...

Patient Case: Frontline Treatment Options for HER2+ mBC
https://www.onclive.com/view/patient-case-frontline-treatment-options-for-her2-mbc

Feb 2nd, 2022 - Vijayakrishna Gadi, MD, PhD: We have a little more information on this patient. We find out from the breast biopsy that she’s got 1 of these HER2 [human epidermal growth factor receptor 2]–enriched phenotypes. She’s hormone receptor–negative for e...

Product update: Breast biopsy system, tamponade mini-sponge, ovulation prediction device and app
https://www.mdedge.com/obgyn/article/235545/gynecology

Feb 4th, 2021 - Updated option for breast biopsy Hologic announces updates to its Brevera® Breast Biopsy System with CorLumina® Imaging Technology. The Brevera system is designed for use with the manufacturer’s Affirm® Prone biopsy guidance system.

Dr. Blanco on the Role of Pathology in Treatment of Breast Cancer
https://www.onclive.com/view/dr-blanco-discusses-the-role-of-pathology-in-treatment-of-breast-cancer

Dec 20th, 2020 - Luis Z. Blanco Jr., MD, assistant professor of pathology, Northwestern University, discusses the role a pathologist plays in the treatment of a patient with breast cancer in an interview with OncLive during the Lynn Sage Breast Cancer Symposium. ...

USPSTF recommends preventive breast cancer medications only for women at risk
https://www.mdedge.com/hematology-oncology/article/207410/breast-cancer/uspstf-recommends-preventive-breast-cancer
Heidi Splete

Sep 3rd, 2019 - Medication to help prevent breast cancer is not recommended for women without increased risk, but could benefit women at increased risk for the disease, according to an update from the U. S.

see more →

Patient Education  12 results see all →